These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27281440)

  • 1. Cost of Medications Recommended by Canadian Acne Clinical Practice Guidelines.
    Czilli T; Tan J; Knezevic S; Peters C
    J Cutan Med Surg; 2016 Nov; 20(6):542-545. PubMed ID: 27281440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines of care for the management of acne vulgaris.
    Reynolds RV; Yeung H; Cheng CE; Cook-Bolden F; Desai SR; Druby KM; Freeman EE; Keri JE; Stein Gold LF; Tan JKL; Tollefson MM; Weiss JS; Wu PA; Zaenglein AL; Han JM; Barbieri JS
    J Am Acad Dermatol; 2024 May; 90(5):1006.e1-1006.e30. PubMed ID: 38300170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination topical therapy in the treatment of acne.
    Del Rosso JQ
    Cutis; 2006 Aug; 78(2 Suppl 1):5-12. PubMed ID: 17966494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
    Langner A; Chu A; Goulden V; Ambroziak M
    Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
    Gonzalez P; Vila R; Cirigliano M
    J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blind study of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100 mg.
    Gold LS; Cruz A; Eichenfield L; Tan J; Jorizzo J; Kerrouche N; Dhuin JC
    Cutis; 2010 Feb; 85(2):94-104. PubMed ID: 20349684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid].
    Worret WI; Fluhr JW
    J Dtsch Dermatol Ges; 2006 Apr; 4(4):293-300. PubMed ID: 16638058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the use of adapalene 0.1%/benzoyl peroxide 2.5% to treat patients with moderate to severe acne.
    Leyden J
    J Dermatolog Treat; 2016; 27 Suppl 1():S4-13. PubMed ID: 26947815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of acne.
    Liao DC
    J Fam Pract; 2003 Jan; 52(1):43-51. PubMed ID: 12540312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.
    Zaenglein AL; Shamban A; Webster G; Del Rosso J; Dover JS; Swinyer L; Stein L; Lin X; Draelos Z; Gold M; Thiboutot D
    J Drugs Dermatol; 2013 Jun; 12(6):619-25. PubMed ID: 23839176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin.
    Tan J; Humphrey S; Vender R; Barankin B; Gooderham M; Kerrouche N; Audibert F; Lynde C;
    Br J Dermatol; 2014 Dec; 171(6):1508-16. PubMed ID: 24934963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Acne Vulgaris: A Review.
    Eichenfield DZ; Sprague J; Eichenfield LF
    JAMA; 2021 Nov; 326(20):2055-2067. PubMed ID: 34812859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic acne therapy].
    Thielitz A; Gollnick H
    J Dtsch Dermatol Ges; 2005 May; 3(5):366-78; quiz 379-80, 382. PubMed ID: 16372805
    [No Abstract]   [Full Text] [Related]  

  • 14. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.
    Gollnick HP; Draelos Z; Glenn MJ; Rosoph LA; Kaszuba A; Cornelison R; Gore B; Liu Y; Graeber M;
    Br J Dermatol; 2009 Nov; 161(5):1180-9. PubMed ID: 19466959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged ≥ 12 years.
    Keating GM
    Am J Clin Dermatol; 2011 Dec; 12(6):407-20. PubMed ID: 21967116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance therapy for acne vulgaris: efficacy of a 12-month treatment with adapalene-benzoyl peroxide after oral isotretinoin and a review of the literature.
    Bettoli V; Borghi A; Zauli S; Toni G; Ricci M; Giari S; Virgili A
    Dermatology; 2013; 227(2):97-102. PubMed ID: 24029411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of adapalene 0.1%/benzoyl peroxide 2.5% topical gel on quality of life and treatment adherence during long-term application in patients with predominantly moderate acne with or without concomitant medication - additional results from the non-interventional cohort study ELANG.
    Gollnick HP; Friedrich M; Peschen M; Pettker R; Pier A; Streit V; Jöstingmeyer P; Porombka D; Rojo Pulido I; Jäckel A
    J Eur Acad Dermatol Venereol; 2015 Jun; 29 Suppl 4():23-9. PubMed ID: 26059731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of adapalene 0.1% / benzoyl peroxide 2.5% in the long-term treatment of predominantly moderate acne with or without concomitant medication - results from the non-interventional cohort study ELANG.
    Gollnick HP; Friedrich M; Peschen M; Pettker R; Pier A; Streit V; Jöstingmeyer P; Porombka D; Rojo Pulido I; Jäckel A
    J Eur Acad Dermatol Venereol; 2015 Jun; 29 Suppl 4():15-22. PubMed ID: 26059730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of isotretinoin in the treatment of acne. Part 3. A cost-minimisation pharmaco-economic model.
    Wessels F; Anderson AN; Kropman K
    S Afr Med J; 1999 Jul; 89(7 Pt 2):791-4. PubMed ID: 10470319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update and future of systemic acne treatment.
    Zouboulis CC; Piquero-Martin J
    Dermatology; 2003; 206(1):37-53. PubMed ID: 12566804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.